305 related articles for article (PubMed ID: 20848993)
41. Localization of angiogenic growth factors and their receptors in the human placental bed throughout normal human pregnancy.
Schiessl B; Innes BA; Bulmer JN; Otun HA; Chadwick TJ; Robson SC; Lash GE
Placenta; 2009 Jan; 30(1):79-87. PubMed ID: 19010534
[TBL] [Abstract][Full Text] [Related]
42. Lymphangiogenesis by blind-ended vessel sprouting is concurrent with hemangiogenesis by vascular splitting.
Parsons-Wingerter P; McKay TL; Leontiev D; Vickerman MB; Condrich TK; Dicorleto PE
Anat Rec A Discov Mol Cell Evol Biol; 2006 Mar; 288(3):233-47. PubMed ID: 16489601
[TBL] [Abstract][Full Text] [Related]
43. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
[TBL] [Abstract][Full Text] [Related]
44. Tie1 controls angiopoietin function in vascular remodeling and inflammation.
Korhonen EA; Lampinen A; Giri H; Anisimov A; Kim M; Allen B; Fang S; D'Amico G; Sipilä TJ; Lohela M; Strandin T; Vaheri A; Ylä-Herttuala S; Koh GY; McDonald DM; Alitalo K; Saharinen P
J Clin Invest; 2016 Sep; 126(9):3495-510. PubMed ID: 27548530
[TBL] [Abstract][Full Text] [Related]
45. Angpt1 binding to Tie1 regulates the signaling required for lymphatic vessel development in zebrafish.
Morooka N; Gui N; Ando K; Sako K; Fukumoto M; Hasegawa U; Hußmann M; Schulte-Merker S; Mochizuki N; Nakajima H
Development; 2024 May; 151(10):. PubMed ID: 38742432
[TBL] [Abstract][Full Text] [Related]
46. Lymphangiogenic growth factors, receptors and therapies.
Lohela M; Saaristo A; Veikkola T; Alitalo K
Thromb Haemost; 2003 Aug; 90(2):167-84. PubMed ID: 12888864
[TBL] [Abstract][Full Text] [Related]
47. Angiopoietin/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data.
Joussen AM; Ricci F; Paris LP; Korn C; Quezada-Ruiz C; Zarbin M
Eye (Lond); 2021 May; 35(5):1305-1316. PubMed ID: 33564135
[TBL] [Abstract][Full Text] [Related]
48. Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expression.
Korhonen EA; Murtomäki A; Jha SK; Anisimov A; Pink A; Zhang Y; Stritt S; Liaqat I; Stanczuk L; Alderfer L; Sun Z; Kapiainen E; Singh A; Sultan I; Lantta A; Leppänen VM; Eklund L; He Y; Augustin HG; Vaahtomeri K; Saharinen P; Mäkinen T; Alitalo K
J Clin Invest; 2022 Aug; 132(15):. PubMed ID: 35763346
[TBL] [Abstract][Full Text] [Related]
49. Role of Angiopoietin-Tie axis in vascular and lymphatic systems and therapeutic interventions.
Wang R; Yang M; Jiang L; Huang M
Pharmacol Res; 2022 Aug; 182():106331. PubMed ID: 35772646
[TBL] [Abstract][Full Text] [Related]
50. FOXC2 transcription factor: a novel regulator of lymphangiogenesis.
Wu X; Liu NF
Lymphology; 2011 Mar; 44(1):35-41. PubMed ID: 21667821
[TBL] [Abstract][Full Text] [Related]
51. Tie2 as a novel key factor of microangiopathy in systemic sclerosis.
Moritz F; Schniering J; Distler JHW; Gay RE; Gay S; Distler O; Maurer B
Arthritis Res Ther; 2017 May; 19(1):105. PubMed ID: 28545512
[TBL] [Abstract][Full Text] [Related]
52. In vivo actions of angiopoietins on quiescent and remodeling blood and lymphatic vessels in mouse airways and skin.
Kim KE; Cho CH; Kim HZ; Baluk P; McDonald DM; Koh GY
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):564-70. PubMed ID: 17194894
[TBL] [Abstract][Full Text] [Related]
53. The dynamic roles of angiopoietins in tumor angiogenesis.
Yu Q
Future Oncol; 2005 Aug; 1(4):475-84. PubMed ID: 16556024
[TBL] [Abstract][Full Text] [Related]
54. Downregulation of angiopoietin-1 and Tie2 in chronic hypoxic pulmonary hypertension.
Yamamoto A; Takahashi H; Kojima Y; Tsuda Y; Morio Y; Muramatsu M; Fukuchi Y
Respiration; 2008; 75(3):328-38. PubMed ID: 18073453
[TBL] [Abstract][Full Text] [Related]
55. Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders.
Akwii RG; Mikelis CM
Drugs; 2021 Oct; 81(15):1731-1749. PubMed ID: 34586603
[TBL] [Abstract][Full Text] [Related]
56. Tie-1: A potential target for anti-angiogenesis therapy.
Yang P; Chen N; Jia JH; Gao XJ; Li SH; Cai J; Wang Z
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):615-622. PubMed ID: 26489611
[TBL] [Abstract][Full Text] [Related]
57. Switching of vascular phenotypes within a murine breast cancer model induced by angiopoietin-2.
Reiss Y; Knedla A; Tal AO; Schmidt MHH; Jugold M; Kiessling F; Burger AM; Wolburg H; Deutsch U; Plate KH
J Pathol; 2009 Mar; 217(4):571-80. PubMed ID: 19116989
[TBL] [Abstract][Full Text] [Related]
58. Angiopoietin-2-induced blood-brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling.
Gurnik S; Devraj K; Macas J; Yamaji M; Starke J; Scholz A; Sommer K; Di Tacchio M; Vutukuri R; Beck H; Mittelbronn M; Foerch C; Pfeilschifter W; Liebner S; Peters KG; Plate KH; Reiss Y
Acta Neuropathol; 2016 May; 131(5):753-73. PubMed ID: 26932603
[TBL] [Abstract][Full Text] [Related]
59. Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2.
Saharinen P; Kerkelä K; Ekman N; Marron M; Brindle N; Lee GM; Augustin H; Koh GY; Alitalo K
J Cell Biol; 2005 Apr; 169(2):239-43. PubMed ID: 15851516
[TBL] [Abstract][Full Text] [Related]
60. Stereological and immunogold studies on TIE1 and TIE2 localization in glomeruli indicate angiopoietin signaling in podocytes.
Logothetidou A; De Spiegelaere W; Van den Broeck W; Vandecasteele T; Couck L; Simoens P; Cornillie P
Micron; 2017 Jun; 97():6-10. PubMed ID: 28288344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
